<code id='78098D5BBD'></code><style id='78098D5BBD'></style>
    • <acronym id='78098D5BBD'></acronym>
      <center id='78098D5BBD'><center id='78098D5BBD'><tfoot id='78098D5BBD'></tfoot></center><abbr id='78098D5BBD'><dir id='78098D5BBD'><tfoot id='78098D5BBD'></tfoot><noframes id='78098D5BBD'>

    • <optgroup id='78098D5BBD'><strike id='78098D5BBD'><sup id='78098D5BBD'></sup></strike><code id='78098D5BBD'></code></optgroup>
        1. <b id='78098D5BBD'><label id='78098D5BBD'><select id='78098D5BBD'><dt id='78098D5BBD'><span id='78098D5BBD'></span></dt></select></label></b><u id='78098D5BBD'></u>
          <i id='78098D5BBD'><strike id='78098D5BBD'><tt id='78098D5BBD'><pre id='78098D5BBD'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:541
          Adobe

          SAN DIEGO — After starting off the year with lower revenue projections than market analysts had hoped for, San Diego-based genomics giant Illumina lowered expectations again on Wednesday, forecasting annual growth of 1% compared to the previous year.

          The market’s response was swift. Minutes after the company issued its press release, shares in Illumina dipped from $184.49 to below $172 during after-hours trading.

          advertisement

          In its release, Illumina noted that it expects revenue from the company’s core business to be essentially the same this year compared to last, and that it expects revenue from Grail, the cancer diagnostics company that Illumina acquired for $8 billion in the fall of 2021, to remain in the range of $90 and $100 million.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Chamber of Commerce, DOJ clash in court over drug prices
          Chamber of Commerce, DOJ clash in court over drug prices

          TheU.S.ChamberofCommercesuedtostopanewMedicaredrugpricenegotiationprogramfromgoingintoeffect.AdobeWA

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Midwives could help bridge maternal health disparities in the U.S.

          HANNAHMCKAY/POOL/AFPviaGettyImagesInthewakeofgrowingalarmoverthedisproportionatelyhighratesofmaterna